Up-regulation of NICE-3 as a Novel EDC Gene Could Contribute to Human Hepatocellular Carcinoma |
Wei, Yuan-Jiang
(Department of Hepatobiliary Surgery, Wuxi Municipal People's Hospital of Nanjing Medical University)
Hu, Qin-Qin (Deaprtment of Pain Treatment, The Affiliated Hospital of Jiujiang University) Gu, Cheng-Yu (Department of Hepatobiliary Surgery, Wuxi Municipal People's Hospital of Nanjing Medical University) Wang, Yu-Ping (Chinese National Human Genome Center, Rui-Jin Hospital, Shanghai Jiaotong University School of Medicine) Han, Ze-Guang (Chinese National Human Genome Center, Rui-Jin Hospital, Shanghai Jiaotong University School of Medicine) Cai, Bing (Department of Hepatobiliary Surgery, Wuxi Municipal People's Hospital of Nanjing Medical University) |
1 | Andrew M, Jamel M, Mark H (2010). Hepatitis C virus NS5A protein interacts with -catenin and stimulates its transcriptional activity in a phosphoinositide-3 kinasedependent fashion. Journal of General Virology, 91, 373-81. DOI |
2 | Chung YL, Sheu ML, Yen SH (2003). Hepatitis C Virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int J Cancer, 107, 65-73. DOI |
3 | Deng Q, Wang Q, Zong WY, et al (2010). E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation. Cancer Res, 70, 782-91. DOI ScienceOn |
4 | Elin K, et al (2008). Gene expression variation to predict 10- year survival in lymph-node-negative breast cancer. BMC Cancer, 8, 254-67 DOI ScienceOn |
5 | Gimenez-Barcons M, Wang C, Chen M, et al (2005). The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation. J Interferon Cytokine Res, 2005,152-64. |
6 | Huang J, Lin Y, Li L, Qing D. et al (2009). ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis. Mol Carcinog, 48, 130-40. DOI |
7 | Huang J, Zhang X, Zhang M, et al (2007). Up-regulation of DLKl as an imprinted gene could contribute to hurnan hepatocellular carcinoma. Carcinogenesis, 28,1094-03. |
8 | Huang J, Zhang YL, Teng XM, et al (2007). Down-regulation of SFRPl as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma. BMC Cancer, 7, 126-40. DOI |
9 | Huang J, Zheng DL, Qin FS, et al (2010). Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling. J Clin Invest, 120, 223-41. DOI |
10 | Ingo M, Maja Z, David F, et al (2001). Identification of Human Epidermal Differentiation Complex (EDC)-Encoded Genes by Subtractive Hybridization of Entire YACs to a Gridded Keratinocyte cDNA Library. Genome Res, 11,341-55. DOI |
11 | Kato N, Lan KH, Ono-Nita SK, et al (1997). Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol, 71, 8856-9. |
12 | Keng-Hsin L, Meei-Ling S, Shinn-Jang H, et al (2002). HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene, 21, 4801-11. DOI |
13 | Leung TH, Wong N, Lai PB, et al (2002). Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma. Mod Pathol, 15, 1213-20. DOI |
14 | Moubayed N, et al (2007). Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol, 133, 253-61. DOI |
15 | Maelandsmo GM, Florenes VA, Mellingsaeter T, et al (1997) Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma . Int. J Cancer, 74, 464-9. DOI ScienceOn |
16 | Marenholz I, et al (2011). Association screening in the Epidermal Differentiation Complex (EDC) identifies an SPRR3 repeat number variant as a risk factor for eczema. J Invest Dermatol, 131,1644-9. DOI |
17 | Martin CA, et al (2004). Transcriptomic changes inhuman breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res, 6, 499-13. DOI |
18 | Nasser MW, et al (2012). S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res, 72, 604-15. DOI |
19 | Perz JF, Armstrong GL, Farrington LA, et al (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol, 45, 529-38 DOI |
20 | Rajesh K, et al (2007). Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PHG, and xenobiotic degradation pathways. Human Pathology, 38, 639-44. DOI ScienceOn |
21 | Ruisheng Y, et al (2007). Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res, 27, 3051-8 |
22 | Tripathi SC, Matta A, Kaur J, et al (2010). Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS ONE,5, e11939. DOI |
23 | Zhang QH, Ye M, Wu XY, et al (2000). Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells. Genome Res, 10, 1546-60. DOI ScienceOn |
24 | Wang HX, Li YD, Wang YP, et al (2012). C9orf100, a new member of the Dbl-family guanine nucleotide exchange factors, promotes cell proliferation and migration in hepatocellular carcinoma. Mol Med Report, 5, 1169-74 |
25 | Yang Q, Liu Y, Cheng J, et al (2003). Cloning and identification of gene 4 transactivated by non-structural protein 5A of hepatitis C virus. Chin J Gastro Hepa, 12, 248-50. |